• We are available for your help 24/7
  • Email: info@isindexing.com, submission@isindexing.com

Paper Details

About A Lockdown: Are the Novel Etiological Therapies for the SARS-CoV-2 Effective?  

Echevarria-Castro, Nataly and Fernandez-Aristi, Augusto R*  

Journal Title:Annals of Case Reports & Reviews

Even though the humankind is familiar to disease outbreaks and pandemics, one of the few that has negatively impacted not only public health, but economy, finances among other vital government sectors is the COVID-19 caused by the SARS-CoV-2. These Viral family are common pathogens that can cause a variety of clinical entities, from respiratory symptoms to gastrointestinal ones ranging from mild to death threating cases. Many countries worldwide had already reported numerous index and imported cases and the death toll continues to trend up most dramatically in European and Asian countries. For this reason, one of the main strategies to control and contain the widespread dissemination of the virus are social isolation and even lockdown. In spite this measure, the number of cases continues to trend up with the lethality rate and the burden of the disease slowly increasing. Even though this disease presents a challenge, not only in diagnosis, but in specific etiological treatment, many researchers are developing many SARS-CoV-2 specific drugs and agents to decrease the alarming numbers of mortality and death toll. Given those treatments are novel, most of them have increasingly growing information regarding effectiveness and safety. In this article, we will try to compilate all the current novel therapies that are currently being developed for this on-growing pandemic.